Trials / Withdrawn
WithdrawnNCT01317810
A Study Measuring and Tracking Changes in Overactive Bladder (OAB) Medication
A Phase 4, Observational, Non-interventional Study Measuring and Tracking Changes in Overactive Bladder Medication and/or Overactive Bladder Medication Dose in Subjects With Overactive Bladder
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to track changes in overactive bladder (OAB) medical regimen and/or OAB medication dosage requirements.
Detailed description
Subjects will complete a study specific survey questionnaire at Screening and the Month 1 through Month 6 visits. Subjects will be followed for 6 months.
Conditions
Timeline
- First posted
- 2011-03-17
- Last updated
- 2015-09-02
Source: ClinicalTrials.gov record NCT01317810. Inclusion in this directory is not an endorsement.